Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio

Vector Science & Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced an exclusive licensing and manufacturing agreement with LyoGenesis Plus ("LyoGenesis"), a cGMP ...

Darryl Drake Jr. Named President of Valor as Vector Science and Therapeutics Targets the Performance Medicine Market

Vector Science and Therapeutics Corp. (TSXV: PAIN), a pharmaceutical-grade peptide and precision drug delivery company, today ...

Vector Science & Therapeutics Appoints Darryl Drake Jr. as President of Valor

Newly Formed Sports Medicine Division Taps Experienced Leader to Build Elite Athlete Network and Distribution Channel MEQUON, Wis., June 8, 2026 /PRNewswire/ -- Vector Science & Therapeutics Corp.

Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform

Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the filing of a provisional patent application covering a ...

Vector Science & Therapeutics Names Dexter Fowler as Chief Athletic Officer for Its Valor Platform

Year MLB Veteran and 2016 World Series Champion Joins Valor, Vector's Athlete Platform, to Make Sure the Next Generation Plays Longer and Hurts Less MEQUON, Wis., June 12, 2026 /PRNewswire/ -- Vector ...
Business Wire

TSCP Portfolio Companies Vector Laboratories and Absolute Biotech Announce Merger, Strengthening Support for Life Science Customers

ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the merger of its portfolio companies, Vector Laboratories and Absolute ...

Valor by Vector Science & Therapeutics: Darryl Drake Jr. Named President of Valor as Vector Science and Therapeutics Targets the Performance Medicine Market

Vector Science and Therapeutics Corp. (TSXV: PAIN), a pharmaceutical-grade peptide and precision drug delivery company, today announced that ...

Vector Sciences & Therapeutics: Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform

Proprietary Magnetic Patch System Delivers Regenerative Peptides to Targeted Tissue Without Injection, with Built-In Confirmation of Successful Delivery MEQUON, Wis.